Mark A. Glickman - Insider Trading & Ownership

Entity
Individual
Location
C/O Esperion Therapeutics, Inc., 3891 Ranchero Drive, Suite 150, Ann Arbor, MI
Summary
The estimated net worth of Mark A. Glickman is at least $46K dollars as of June 7, 2024. Mark A. Glickman is the Director of NeuroBo Pharmaceuticals, Inc. and owns shares of NeuroBo Pharmaceuticals, Inc. (NRBO) stock worth about $30.5K. Mark A. Glickman is the Co-Chief Executive Officer of TherapeuticsMD, Inc. and owns shares of TherapeuticsMD, Inc. (TXMD) stock worth about $15.5K.
All Insider Reports
All Insider Reports

Ownership of Mark A. Glickman

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
NRBO NeuroBo Pharmaceuticals, Inc. Director $30.5K Jun 7, 2024
TXMD TherapeuticsMD, Inc. Co-Chief Executive Officer $15.5K Dec 6, 2022

Insider Transactions Reported by Mark A. Glickman:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.